期刊
EXPERT REVIEW OF VACCINES
卷 8, 期 1, 页码 113-120出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.8.1.113
关键词
preclinical model; severe combined immunodeficient mice; vaccine development
类别
资金
- NIH [CA23766, CA59350]
- Burton Abrams Charitable Trust
- Ryan E McGeough Charitable Fund
- The Aubrey Fund for Pediatric Cancer Research
- The Larry H Smead Foundation
- Commonwealth Foundation for Cancer Research
- The Claire L Tow Chair in Pediatric Oncology Research
- NATIONAL CANCER INSTITUTE [P01CA059350, P01CA023766] Funding Source: NIH RePORTER
The severe combined immunodeficient (SCID) mouse has no adaptive immunity, lacking mature T and B cells in the peripheral blood or the lymphoid organs. It has been used extensively in biomedical research as a valuable translational model for xeno-engraftment of human tissues and cells. This review focuses on the engraftment of human peripheral blood cells and tissues in SCID mice, as well as in the newly established and more permissive SCID mice deficient in the IL-2 receptor gamma-chain. Human immune responses could be elicited and assessed in these humanized SCID mice upon vaccination or sensitization with allogeneic tissues. A translational model is proposed to attain preclinical data for testing human vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据